LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications

Author(s):  Gilbert John A

Issue:  Sep/Oct 2009 - Veterinary Compounding
View All Articles in Issue

Abstract:  The practice of pharmaceutical compounding may involve the dispensing of controlled substances, a subset of prescription drug products. In such cases, the Drug Enforcement Administration has authority to regulate and enforce pharmacy compounding in the U.S. through the Controlled Substances Act and Drug Enforcement Administration regulations, although the Drug Enforcement Administration expressly acknowledges that the agency does not establish medical standards or guidelines on the treatment of pain. There is a need to balance the interests of law enforcement in reducing the potential for prescription drug abuse without adversely affecting the need to ensure appropriate availability and access to pain medicine. Compounding pharmacies provide an important service to practitioners and their patients suffering from chronic pain and debilitating illness. Without access to pain medicine, a patient’s needs would go unmet, resulting in unnecessary pain and suffering.

Related Keywords: John A. Gilbert, Jr., Esq, prescription drug abuse, controlled substances, U.S. Drug Enforcement Administration, DEA, law enforcement, Model Guidelines, pain medication, medical practice standards, online pharmacy, internet

Related Categories: LEGAL, PAIN MANAGEMENT

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A Sep/Oct 2009 400-403 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A Nov/Dec 2011 526-527 Buy
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Pore R David Nov/Dec 2012 446-450 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake Sep/Oct 2015 377-380 Buy
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna Nov/Dec 2012 456-460 Buy
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Miller David G Mar/Apr 2012 94-96 View Sample